Client News

CEVEC Announces the Launch of the ELEVECTA® Platform – the Stable Producer Cell Line Technology for AAV Gene Therapy Vectors

Heidelberg Pharma AG Raises EUR 14.4 Million From Private Placement

Heidelberg Pharma AG Plans Capital Increase to Fund Its ATAC Development Program

4basebio AG Reports positive Financial Results for Fiscal Year 2019 – Financial Guidance Met

LEUKOCARE AG: ReiThera, LEUKOCARE and Univercells announce pan-European consortium for the fast-track development of a single-dose adenovirus-based COVID-19 vaccine

Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2020

ReiThera, LEUKOCARE and Univercells announce pan-European consortium for the fast-track development of a single-dose adenovirus-based COVID-19 vaccine

4basebio provides Phi29 DNA polymerase variants and expertise to develop improved detection system for SARS-CoV-2 infection

CENTOGENE Releases a New Swab Product to Facilitate the Simple Diagnosis of COVID-19

CENTOGENE AG: „Mittelstandsinitiative COVID-19“ zur Bekämpfung des Corona-Virus zeigt Wirkung